Accurate screening of patients with diabetes based on physical examination: pancreas imaging features from chest CT and laboratory data
- PMID: 41384020
- PMCID: PMC12689402
- DOI: 10.3389/fendo.2025.1698247
Accurate screening of patients with diabetes based on physical examination: pancreas imaging features from chest CT and laboratory data
Abstract
Background: Fasting plasma glucose (FBG) was used in the large-scale primary screening of diabetes mellitus (DM). However, some people who actually have DM have normal fasting glucose (NFG), which shows a high false negative rate.
Objective: To investigate the application value of pancreatic radiomics features and laboratory data from chest CT scan in screening DM patients.
Methods: Patients with DM were diagnosed according to HbA1c≥48 mmol/mol(6.5%). The radiomics features of pancreas in lung window (L) and soft tissue window (S) of chest CT and laboratory data of 3587 patients from D1 (model training and testing) and D2/D3/D4/D5 (external validation) were retrospectively analyzed to construct a diagnostic model for DM screening.
Results: The AUC of the lung window-laboratory models (L-Lab-LR and L-Lab-SVM) in the test set were 0.958/0.965. The AUC of soft tissue windows-clinical models (S-Lab-LR and S-Lab-SVM) were 0.958/0.969, 0.875/0.881, 0.935/0.959, 0.905/0.919, respectively.
Conclusions: The diagnostic model based on chest CT pancreatic radiomics features and laboratory data has a very high diagnostic efficiency, which is accurate and reliable for the initial screening of DM patients. This method will facilitate early diagnosis of those individuals with DM who may have been missed.
Keywords: CT; diabetes mellitus; diagnostic model; fasting blood glucose; pancreas.
Copyright © 2025 Yi, Lin, Feng, Huang, Li, Liang, Wu, Yan, Yang, Wu, Liang, Liu, Chen, Xu and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Green JB, Everett BM, Ghosh A, Younes N, Krause-Steinrauf H, Barzilay J, et al. Cardiovascular outcomes in GRADE (Glycemia reduction approaches in type 2 diabetes: A comparative effectiveness study). Circulation. (2024) 149:993–1003. doi: 10.1161/CIRCULATIONAHA.123.066604, PMID: - DOI - PMC - PubMed
-
- Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, et al. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Cochrane Database Syst Rev. (2022) 2:CD014217. doi: 10.1002/14651858.CD014217, PMID: - DOI - PMC - PubMed
-
- Federation ID. IDF diabetes atlas, 10th ed. Liuzhou: (2021)
-
- Redondo MJ, Warnock MV, Libman IM, Bocchino LE, Cuthbertson D, Geyer S, et al. TCF7L2 genetic variants do not influence insulin sensitivity or secretion indices in autoantibody-positive individuals at risk for type 1 diabetes. Diabetes Care. (2021) 44:2039–44. doi: 10.2337/dc21-0531, PMID: - DOI - PMC - PubMed
-
- Nanditha A, Thomson H, Susairaj P, Srivanichakorn W, Oliver N, Godsland IF, et al. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India and the UK: a randomised controlled trial. Diabetologia. (2020) 63:486–96. doi: 10.1007/s00125-019-05061-y, PMID: - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
